Patents by Inventor XIANGGUM LI

XIANGGUM LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY
    Publication number: 20240131096
    Abstract: The present disclosure provides methods of treating cancer using complementary transgenic oncolytic viruses and genetically engineered CAR T cells. In one embodiment, the oncolytic virus comprises nucleotide sequences encoding CD19, or CD19 and IL-12, and the genetically engineered T cells express a chimeric antigen receptor that recognizes CD19.
    Type: Application
    Filed: October 23, 2023
    Publication date: April 25, 2024
    Applicants: Broaden Bioscience and Technology Corp, Orgenesis, Inc, Joint BioSciences Ltd
    Inventors: BUO CHEN, GUOQING ZHOU, XIANGGUM LI